Check out your Company Bowl for anonymous work chats.
What would healthcare look like if we could finally connect the dots? Join us at SXSW 2026 as we discuss "How AI Enables a Radical Shift in Understanding Your Health." Care is still episodic and fragmented, but this panel will explore how AI-powered tools are connecting disparate data—from wearables to health records—to unlock personalized, preventative, and whole-person care while ensuring data safety and privacy. Speakers: → Vindell Washington, MD, Chief Clinical Officer, Verily → John Gerzema, CEO, The Harris Poll → Arundhati Parmar, Moderator, VP and Editor-in-Chief, MedCity News Mark your calendar for March 17th at 2:30 PM, The LINE - Topaz Ballroom, Austin, TX.
Join Verily Distinguished Engineer David Glazer at the 25th PMWC - Precision Medicine World Conference on March 5th for the session: Keys to Successful Implementation of a Precision Medicine Program. Sharing insights on how technology enables precision medicine, he will join co-panelists Kevan Simms, MBA, PMP, David H. Ledbetter, PhD, FACMG, Mark Atalla, Susanne Munksted, and chair Howard McLeod. David will discuss his experience leading Workbench development at Verily and empowering 21K+ researchers through The National Institutes of Health's All of Us Research program.
Behind every blood pressure reading is a person navigating real life. For lasting heart health, care must see and respond to the whole person — their clinical readings, motivations, challenges, lifestyle, and more. Verily Lightpath’s clinician-led programs pair licensed providers with AI-enabled support to deliver empathic care with proven strategies for inspiring sustainable, healthy change that are humanized — and personalized — for each journey, such as our BeST framework. It’s a brighter way to care for ❤️ health.
We're proud to power the updated The National Institutes of Health (NIH) All of Us Research Program Researcher Workbench using Verily Workbench on our secure precision health platform, Pre. This collaboration ensures the fast-growing 21,500+ All of Us researcher community has access to the most advanced tools to unlock insights from a dataset of over 633,000 participants—including whole genome sequences, electronic health records, and more. By providing powerful, secure analysis capabilities, we're helping to advance medical research and enable more impactful science at scale.
AI is a mirror of our world, and it takes thoughtful design to achieve its promise for precision health. This was a powerful takeaway from Verily Associate Chief Clinical Officer Carolyn Bradner Jasik, MD's talk at ViVE 2026. She highlighted the "Garbage In, Garbage Out" dilemma in healthcare data: ✨ Data in healthcare is like a puzzle where half the pieces are missing, and the rest are from different boxes. Harmonization is needed to see the full picture. ✨ To achieve mathematical fairness, we must intentionally design AI agents and check that models address issues across a broad range of populations to ensure the model runs properly for everyone. ✨ The biggest hurdle to precision medicine isn't the code; it's figuring out how to enable data sharing.
Unstructured clinical data is holding precision health back. A recent project with UCHealth, the University of Colorado Anschutz, and RefinedScience highlighted the potential for AI to break through this barrier. Discover how our Knowledge Graph-augmented platform, built with clinical expertise, delivers high-fidelity evidence at scale.
Will you be at HIMSS26? Don't miss your chance to see the power of Verily Pre in action. Stop by Booth #5047 for a live demo of Verily Pre Refinery, the curation engine that transforms multimodal data into a structured, research and AI-ready asset.
Beyond the genome: the next frontier in precision health is not just sequencing, but resolving complex clinical data. Our work with UCHealth, University of Colorado Anschutz and RefinedScience shows how: → We’ve seen AI accuracy jump from 72% to over 95% by grounding Large Language Models in clinical Knowledge Graphs. → This precision data is being used to identify new patient subclasses, holding the potential to rescue previously shelved therapeutics (like cusatuzumab) for significant commercial impact. This is the AI-driven future of disease classification.
See Verily's AI in action and visit booth #2036 at #ViVEvent for live demos of our AI companion, Violet! Violet helps deliver highly personalized support—anytime—through our Lightpath care programs, delivered via the Verily Me app. 🎯 Set personal, measurable goals 🥗 Log your meal 📋 Reveal your health history 💬 Ask about symptoms Learn more: https://lp.verily.com/1436-vive-2026.html
Exciting news for the research community! We announced the launch of free self-serve access to our Verily Pre Exchange and Workbench solutions. Individual researchers can now instantly use Verily's data ecosystem and secure analysis environment with a Standard tier account. This significantly lowers the barrier to accessing and analyzing diverse biomedical datasets. Plus, we're growing our data ecosystem with new datasets to be available from: ✳️ RefinedScience: Bringing high-quality Longitudinal AML data, including single-cell transcriptomics. ✳️ Segmed, Inc.: Contributing real-world longitudinal imaging and clinical data. ✳️ Transcripta Bio: Adding a high-resolution CRISPRi dataset for accelerating rare disease discovery.
